San Diego – The oral GLP-1 receptor agonist (GLP-1-RA) orforglipron can alleviate sleep apnea. The data from the ATTAIN-OSA studies presented at the American Heart Association (AHA) Annual Meeting in Chicago show a decrease in the Apnea-Hypopnea Index (AHI). Results were reported simultaneously in JAMA (2026; DOI: 10.1001/jama.2026.24080)...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
San Diego – The oral GLP-1 receptor agonist (GLP-1-RA) orforglipron can alleviate sleep apnea. The data from the ATTAIN-OSA studies presented at the American Heart Association (AHA) Annual Meeting in Chicago show a decrease in the Apnea-Hypopnea Index (AHI). Results were reported simultaneously in JAMA (2026; DOI: 10.1001/jama.2026.24080)...